Inactive Instrument
Company C.R. Bard
Stocks
BCR
US0673831097
Medical Equipment, Supplies & Distribution
Business description: C.R. Bard

- vascular (27.3%);
- oncology (27.3%);
- urology (25.6%);
- surgical specialties (17.2%);
- other (2.6%).
Net sales are distributed geographically as follows: the United States (68.9%), Asia/Pacific (13.2%), Europe (12%) and other (5.9%).
Executive Committee: C.R. Bard
| Manager | Title | Age | Since |
|---|---|---|---|
Rian Seger
CEO | Chief Executive Officer | - | - |
Laura Frost
DFI | Director of Finance/CFO | - | - |
Stephanie Kelly
SEC | Corporate Secretary | - | - |
Company details: C.R. Bard
C. R. Bard, Inc. (New Jersey)
1 Becton Drive
07417-1880, Franklin Lakes
+(908) 277-8000
http://www.crbard.com
Group companies: C.R. Bard
| Name | Category and Sector |
|---|---|
Bard Ltd. (United Kingdom)
Bard Ltd. (United Kingdom) BiotechnologyHealth Technology Manufactures biofeedback equipments |
Biotechnology
|
Bard Australia Pty Ltd.
Bard Australia Pty Ltd. Medical SpecialtiesHealth Technology Manufactures and distributes medical and surgical devices |
Medical Specialties
|
C. R. Bard GmbH
C. R. Bard GmbH Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and equipment |
Medical Specialties
|
Bard Dublin ITC Ltd.
Bard Dublin ITC Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services |
Miscellaneous Commercial Services
|
Bard Canada, Inc.
Bard Canada, Inc. Medical SpecialtiesHealth Technology Hospital & surgical specialties |
Medical Specialties
|
Other Medical Equipment, Supplies & Distribution
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.20% | +4.06% | -12.07% | +11.11% | 195B | ||
| +2.24% | +3.80% | +4.79% | +15.44% | 118B | ||
| +0.79% | +1.34% | +8.03% | +75.91% | 60.33B | ||
| -3.33% | -2.29% | +28.78% | +61.62% | 55.1B | ||
| +3.80% | +2.08% | -5.37% | -32.01% | 49.24B | ||
| +2.30% | +0.72% | +13.04% | -12.64% | 33.81B | ||
| +0.89% | -2.99% | - | - | 29.94B | ||
| +2.66% | +1.05% | +44.14% | -9.34% | 24.39B | ||
| -4.11% | -4.87% | -11.27% | +20.03% | 23.82B | ||
| Average | +0.81% | -0.56% | +8.76% | +16.27% | 65.5B | |
| Weighted average by Cap. | +1.33% | +0.46% | +2.26% | +18.24% |

















